543329 Stock Overview
A contract development and manufacturing organization (CDMO), manufactures and trades in pharmaceutical products in India and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
No risks detected for 543329 from our risk checks.
Windlas Biotech Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹957.95 |
| 52 Week High | ₹1,197.00 |
| 52 Week Low | ₹397.90 |
| Beta | 0.37 |
| 11 Month Change | -6.32% |
| 3 Month Change | 16.10% |
| 1 Year Change | 121.16% |
| 33 Year Change | 235.36% |
| 5 Year Change | n/a |
| Change since IPO | 135.54% |
Recent News & Updates
Recent updates
Shareholder Returns
| 543329 | IN Life Sciences | IN Market | |
|---|---|---|---|
| 7D | -3.3% | -3.3% | -3.4% |
| 1Y | 121.2% | 46.6% | 27.0% |
Return vs Industry: 543329 exceeded the Indian Life Sciences industry which returned 46.6% over the past year.
Return vs Market: 543329 exceeded the Indian Market which returned 27% over the past year.
Price Volatility
| 543329 volatility | |
|---|---|
| 543329 Average Weekly Movement | 7.0% |
| Life Sciences Industry Average Movement | 6.5% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in IN Market | 9.2% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 543329 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 543329's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 1,154 | Komal Gupta | windlas.com |
Windlas Biotech Limited, a contract development and manufacturing organization (CDMO), manufactures and trades in pharmaceutical products in India and internationally. The company offers CDMO solutions, including product development, licensing, and commercial manufacturing of complex drugs and dosage forms. It also produces nutraceutical supplement products.
Windlas Biotech Limited Fundamentals Summary
| 543329 fundamental statistics | |
|---|---|
| Market cap | ₹20.04b |
| Earnings (TTM) | ₹612.28m |
| Revenue (TTM) | ₹6.96b |
32.7x
P/E Ratio2.9x
P/S RatioIs 543329 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 543329 income statement (TTM) | |
|---|---|
| Revenue | ₹6.96b |
| Cost of Revenue | ₹4.39b |
| Gross Profit | ₹2.57b |
| Other Expenses | ₹1.96b |
| Earnings | ₹612.28m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 29.30 |
| Gross Margin | 36.91% |
| Net Profit Margin | 8.80% |
| Debt/Equity Ratio | 3.2% |
How did 543329 perform over the long term?
See historical performance and comparison